Edition:
India

Lennox International Inc (LII.N)

LII.N on New York Stock Exchange

195.07USD
10:07pm IST
Change (% chg)

$0.74 (+0.38%)
Prev Close
$194.33
Open
$195.08
Day's High
$196.57
Day's Low
$193.73
Volume
73,513
Avg. Vol
94,333
52-wk High
$222.31
52-wk Low
$160.18

Chart for

About

Lennox International Inc. is a provider of climate control solutions. The Company designs, manufactures and markets a range of products for the heating, ventilation, air conditioning and refrigeration (HVACR) markets. It operates through three segments: Residential Heating & Cooling; Commercial Heating & Cooling, and Refrigerati... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $7,774.93
Shares Outstanding(Mil.): 42.18
Dividend: 0.51
Yield (%): 1.11

Financials

  LII.N Industry Sector
P/E (TTM): 26.41 28.50 24.65
EPS (TTM): 6.98 -- --
ROI: 29.39 10.72 7.25
ROE: 1,467.48 12.88 12.43

BRIEF-Lennox International Reports Q1 Adjusted Earnings Per Share $1.13 From Continuing Operations

* LENNOX INTERNATIONAL REPORTS RECORD FIRST-QUARTER REVENUE AND PROFIT

23 Apr 2018

BRIEF-Lennox International Says CEO's 2017 Compensation Was $11.45 Mln

* LENNOX INTERNATIONAL INC SAYS CEO TODD M. BLUEDORN'S 2017 TOTAL COMPENSATION WAS $11.45 MILLION VERSUS $10 MILLION IN 2016 – SEC FILING‍​ Source: (https://bit.ly/2GUhs6F) Further company coverage:

05 Apr 2018

BRIEF-Lennox International Q4 EPS $1.02 From Continuing Operations

* LENNOX INTERNATIONAL REPORTS RECORD FOURTH QUARTER MARGIN AND PROFIT TO CAP RECORD YEAR AND RAISES 2018 EPS GUIDANCE FOR U.S. TAX LEGISLATION

06 Feb 2018

BRIEF-Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation By U.S. FDA For Treatment Of Lennox-Gastaut Syndrome

* OVID THERAPEUTICS ANNOUNCES TAK-935/OV935 GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA FOR TREATMENT OF LENNOX-GASTAUT SYNDROME

20 Dec 2017

BRIEF-Lennox International Sees Fy18 Revenue Up 3 To 7 Percent

* REAFFIRMS FY 2017 ADJUSTED EARNINGS PER SHARE VIEW $7.75 TO $8.05 FROM CONTINUING OPERATIONS

13 Dec 2017

BRIEF-Lennox International says Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated Nov 18, 2011

* Lennox International - ‍as of Nov 13, Lennox, Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated nov 18, 2011

17 Nov 2017

Earnings vs. Estimates